New stapler shows promise in lung cancer surgery

NCT ID NCT07353489

Completed Disease control Sponsor: Ezisurg Medical Co. Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a powered stapler used during lung cancer surgery in 61 patients. The goal was to see if the device was safe and worked well. Researchers checked for leaks and other complications. The study is complete, but results are not yet published.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges (a surgical stapling device)
What this could lead to: If successful, this could show that the powered stapler is a safe and effective tool for lung cancer surgery, potentially reducing complications.
What could go wrong: This was a small, single-arm study with only 61 patients, so results may not apply to everyone. It also only looked back at past records, not a controlled comparison.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER (NSCLC)

Contacts and locations

Locations

Affiliated Hospital of Jining Medical University

Jining, Shandong, 272000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.